Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: Barnstable Town, MA MSA — October 2026
Cape Cod life sci pay outruns thin local talent supply.
Metro Research Scientist pay ($141,716) and Biostatistician pay ($146,366) both exceed national medians even as Clinical Research Associate pay lags the national figure by roughly $8,800, underscoring how a thin regional talent pool prices unevenly against Boston-area competition.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Cape & Islands unemployment: 3.6% — August 2026, vs 4.1% US rate
- Barnstable County employment change: -1.9% — Year-over-year through March 2026
- MA biopharma R&D employment: +2.7% — Early 2026, after -3.9% in 2025
- Cape Cod housing cost growth: +64% — 2019-2023, vs +24% avg weekly wages
Key takeaways
Metro Research Scientist pay already outpaces national rates.
Advertised Research Scientist pay in Barnstable Town sits at $141,716 against a national median of $130,339, even as the national figure is rising sharply. Metro employers hiring into this role appear to be pricing against Boston-area competition rather than local labor costs — a gap worth monitoring as national pay continues to climb.
CRA compensation is diverging from the national pay story.
Clinical Research Associate pay nationally is up significantly to $90,065, yet the metro median of $81,221 trails by roughly $8,800 despite also rising. With CRAs flagged nationally as the hardest clinical role to fill, this gap may pressure metro employers toward remote-based hiring or Boston-anchored pay scales to remain competitive.
Clinical Data Manager pay is softening against a stable national trend.
Metro advertised pay for Clinical Data Manager fell moderately to $123,031 while the national median held stable at $123,653. A declining local figure against flat national demand is inconsistent with the broader tightening in clinical/regulatory talent and may reflect a thin, volatile local sample rather than a genuine demand shift.
Biostatistician pay signals a market pricing in scarce quantitative talent.
Metro Biostatistician pay rose moderately to $146,366, outpacing a flat national median of $131,958. That premium tracks the statewide growth in bioinformatics and biomathematics credentialing noted this year, and reinforces that quantitative scientific roles remain a point of wage pressure even in a smaller metro.
Median advertised pay by role — Barnstable Town, MA MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $111,453 | $141,716 | $152,000 | Stable | $130,339 |
| Clinical Research Associate * | $56,715 | $81,221 | $98,142 | Significant increase | $90,065 |
| Lab Technician * | $43,680 | $54,673 | $60,320 | Stable | $47,840 |
| Regulatory Affairs Specialist * | $84,292 | $117,500 | $132,465 | Stable | $103,780 |
| Clinical Data Manager * | $100,353 | $123,031 | $148,892 | Moderate decline | $123,653 |
| Biostatistician * | $107,561 | $146,366 | $160,280 | Moderate increase | $131,958 |
| Validation Engineer * | $95,530 | $113,236 | $123,552 | Stable | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Barnstable County's life sciences footprint sits inside a labor market defined by seasonal volatility — Cape & Islands unemployment fell to 3.6% in August on tourism-driven hiring before likely reverting as the visitor season ends, while county employment overall declined 1.9% year-over-year through March. Any specialized scientific or regulatory employer in this metro competes for talent against a hospitality and retail sector that, per Cape Cod Chamber reporting, employs nearly half the local workforce and against the broader Boston-Cambridge life sciences cluster roughly 70 miles northwest, where scale and density dominate.
What it means
Thin local density of life sciences employers in this metro means build-vs-outsource decisions for clinical, regulatory, and CMC functions often default toward remote-capable hires or CRO/CDMO partnerships rather than local in-house buildout, since the talent pool simply lacks Cambridge-level depth. Statewide signals — Massachusetts biopharma R&D employment down 3.9% in 2025 but up 2.7% year-over-year in early 2026 — suggest hiring is selectively reopening, and metro employers competing for CRA or regulatory talent should expect candidates to weigh Cape Cod positions against both Boston-metro pay and cost-of-living tradeoffs tied to housing costs that have risen 64% since 2019. Consider evaluating whether specialized roles are better recruited as remote or hybrid positions anchored to Boston-area pay scales rather than local metro benchmarks alone.
Looking ahead
Expected: Cape & Islands unemployment typically rises as the tourism season winds down through November and December; watch whether this seasonal softening pulls lab technician or administrative-adjacent talent into the broader labor pool at lower reservation wages.
Emerging pressure point: Blueprint Medicines' 229-worker Cambridge layoff and Foghorn Therapeutics' 40% reduction add to a thinning Massachusetts biopharma talent pool; monitor whether displaced regulatory, CMC or clinical staff begin surfacing in Cape Cod-area searches given relative housing affordability pressure in Cambridge/Boston proper.
Early indicator: State-level biomanufacturing employment grew by 238 jobs after two years of decline, concentrated in advanced-modality manufacturing. Metro device and diagnostics employers should watch whether this signals renewed in-house build appetite statewide that could tighten validation engineer and bioprocess talent regionally.
Potential inflection point: Massachusetts' $40 million tax-incentive package tied to 1,644 new life sciences jobs, including Insulet's $10 million award, targets mid-stage biotech expansion; track whether any portion of that hiring reaches Barnstable County or remains concentrated in the Boston-Cambridge core.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.